First FDA-Approved Fecal-Based Treatment, Rebyota, Helps Fight a Tough Superbug

THURSDAY, Dec. 1, 2022 -- The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections. " Today ' s approval of Rebyota is...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news